S2Medical ABOSTO:S2M EV-to-FCF is -2.43 as of Jul. 11, 2026. The stock has 3 warning signs investors should review. Among 414 Medical Devices & Instruments companies, S2Medical AB ranks better than 72.71% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, S2Medical AB's Enterprise Value is kr3.96 Mil.
S2Medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-1.63 Mil. Therefore, S2Medical AB's EV-to-FCF for today is -2.43.
The historical rank and industry rank for S2Medical AB's EV-to-FCF or its related term are showing as below:
OSTO:S2M'
s EV-to-FCF Range Over the Past 10 Years
Min: -434.78 Med: -2.57 Max: 80.81
Current: 14.62
During the past 10 years, the highest EV-to-FCF of S2Medical AB was 80.81. The lowest was -434.78. And the median was -2.57.
OSTO:S2M's EV-to-FCF is ranked better than 72.71% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.19
vs OSTO:S2M: 14.62
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
S2Medical AB's PE Ratio (TTM) for today is calculated as:
S2Medical AB's share price for today is kr0.0052.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
S2Medical AB EV-to-FCF Related Terms
S2Medical AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for S2Medical AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, S2Medical AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where S2Medical AB's EV-to-FCF falls into.
S2Medical AB's current Enterprise Value is kr3.96 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. S2Medical AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-1.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (OSTO:S2M) has a EV-to-FCF of -2.43 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on S2Medical AB and its competitors. According to the industry distribution chart, S2Medical AB ranks #113 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 27.3%.
Is S2Medical AB's EV-to-FCF too high?
S2Medical AB's current EV-to-FCF is -2.43. Based on the distribution chart, S2Medical AB ranks #113 out of 414 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does S2Medical AB's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #113 out of 414 companies for EV-to-FCF. This puts S2Medical AB in the upper half of its industry. The industry median EV-to-FCF is 23.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current EV-to-FCF is -2.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.01 — trading 48% below its estimated fair value. The current EV-to-FCF is -2.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current EV-to-FCF is -2.43 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 